Insitrex-TZ 562.5 Injection
Marketer
Insinius Pharmaceuticals
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Insitrex-TZ 562.5 Injection
Insitrex-TZ 562.5 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism halts microbial proliferation, thus containing the infection's spread. Administration must be overseen by a medical professional. Consistent adherence to the prescribed schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation compromises the drug's effectiveness. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects warrant immediate medical attention. Seek emergency care for allergic reactions (e.g., rashes, itching, swelling, respiratory distress). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't impair driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and hydration accelerate recovery. Your doctor might order tests to monitor the medication's impact.
Primary Ingredients of Insitrex-TZ 562.5 Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Insitrex-TZ 562.5 Injection
Infections caused by bacteria
Major Benefits of Insitrex-TZ 562.5 Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Insitrex-TZ 562.5 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Insitrex-TZ 562.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Insitrex-TZ 562.5 Injection works:
Insitrex-TZ 562.5 Injection unites Ceftriaxone, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting crucial bacterial cell wall synthesis. Tazobactum counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Insitrex-TZ 562.5 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Insitrex-TZ 562.5 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human clinical trials are scarce.
Breast feedingCAUTION
The administration of Insitrex-TZ 562.5 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Insitrex-TZ 562.5 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects appear.
KidneyCONSULT YOUR DOCTOR
Data regarding Insitrex-TZ 562.5 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The administration of Insitrex-TZ 562.5 Injection requires careful consideration in individuals with advanced hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Insitrex-TZ 562.5 Injection is generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Insitrex-TZ 562.5 Injection :
Should you inadvertently skip a dose of Insitrex-TZ 562.5 Injection, seek medical advice.
Facts to Know About Insitrex-TZ 562.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently